Pallas Capital Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.81M | Buy |
31,309
+739
| +2% | +$137K | 0.22% | 83 |
|
|
2025
Q1 | $6.4M | Buy |
30,570
+706
| +2% | +$148K | 0.27% | 77 |
|
|
2024
Q4 | $5.31M | Sell |
29,864
-236
| -0.8% | -$41.9K | 0.23% | 89 |
|
|
2024
Q3 | $5.71M | Sell |
30,100
-291
| -1% | -$55.2K | 0.24% | 88 |
|
|
2024
Q2 | $5.2M | Buy |
30,391
+185
| +0.6% | +$31.7K | 0.23% | 93 |
|
|
2024
Q1 | $5.5M | Buy |
30,206
+3,374
| +13% | +$614K | 0.23% | 87 |
|
|
2023
Q4 | $4.16M | Sell |
26,832
-3,093
| -10% | -$479K | 0.22% | 93 |
|
|
2023
Q3 | $4.25M | Buy |
29,925
+6,729
| +29% | +$955K | 0.26% | 80 |
|
|
2023
Q2 | $3.13M | Buy |
23,196
+17,337
| +296% | +$2.34M | 0.14% | 93 |
|
|
2023
Q1 | $961K | Buy |
5,859
+2,305
| +65% | +$378K | 0.09% | 150 |
|
|
2022
Q4 | $532K | Buy |
3,554
+28
| +0.8% | +$4.19K | 0.05% | 177 |
|
|
2022
Q3 | $509K | Buy |
3,526
+31
| +0.9% | +$4.48K | 0.06% | 166 |
|
|
2022
Q2 | $519K | Sell |
3,495
-178
| -5% | -$26.4K | 0.07% | 143 |
|
|
2022
Q1 | $596K | Buy |
3,673
+1,202
| +49% | +$195K | 0.08% | 145 |
|
|
2021
Q4 | $326K | Sell |
2,471
-416
| -14% | -$54.9K | 0.04% | 243 |
|
|
2021
Q3 | $339K | Sell |
2,887
-288
| -9% | -$33.8K | 0.04% | 290 |
|
|
2021
Q2 | $365K | Buy |
3,175
+1,307
| +70% | +$150K | 0.05% | 229 |
|
|
2021
Q1 | $217K | Buy |
+1,868
| New | +$217K | 0.05% | 172 |
|